Virus Therapy
Lenacapavir for HIV Prevention
Recruiting1 awardPhase 3
Los Angeles, California
This trial is testing lenacapavir, a drug that may help prevent HIV. It targets people who are at risk of getting HIV. The drug works by stopping the virus from making more copies of itself. Lenacapavir was developed by Gilead Sciences Inc. and has been approved for use in combination with other treatments.
Behavioral Intervention
Mobile Health Messaging for HIV/AIDS
Recruiting1 award1 criteria
Miami, Florida
This trial will test a new mobile health system that sends text reminders to HIV+ women to help them stick to their treatment plan. The system will also address individual barriers to care, like stigma and mistrust.
Nonsteroidal Anti-inflammatory Drug
Celecoxib +2 More for Cardiovascular Disease
Recruiting5 awardsPhase 4
Falls Church, Virginia
The objectives of this single site, randomized, crossover study is to evaluate the pharmacodynamic interactions between aspirin, NSAIDs and Coxibs with respect to platelet function, biomarkers of inflammation and endothelial function.
Popular Filters
Trials for HIV Patients
Antiretroviral
E/C/F/TAF for HIV-1 Infection
Recruiting1 awardPhase 2 & 3
Long Beach, California
This trial tests a single pill combining four HIV medications in adolescents and children. It aims to find the right dose and ensure safety for those new to treatment and those already on it. The pill works by stopping the virus from growing and spreading.
Phase 3 Trials
Antiretroviral
E/C/F/TAF for HIV-1 Infection
Recruiting1 awardPhase 2 & 3
Long Beach, California
This trial tests a single pill combining four HIV medications in adolescents and children. It aims to find the right dose and ensure safety for those new to treatment and those already on it. The pill works by stopping the virus from growing and spreading.
Cephalosporin Antibiotic
Cefixime vs. Penicillin for Syphilis
Recruiting2 awardsPhase 3
Los Angeles, California
This trial compares two antibiotics, cefixime taken by mouth and benzathine penicillin G given as an injection, to treat early syphilis. It includes patients with and without HIV to find an effective alternative to penicillin. The study aims to help those who are allergic to penicillin or affected by penicillin shortages. Cefixime is being tested as an alternative to penicillin for treating early syphilis, especially for those allergic to penicillin or during penicillin shortages.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.